相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Alpha-Synuclein as a Prominent Actor in the Inflammatory Synaptopathy of Parkinson's Disease
Antonella Cardinale et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Natural Alkaloid Compounds as Inhibitors for Alpha-Synuclein Seeded Fibril Formation and Toxicity
Simona S. Ghanem et al.
MOLECULES (2021)
Structural Optimization of Inhibitors of α-Synuclein Fibril Growth: Affinity to the Fibril End as a Crucial Factor
Kseniia Afitska et al.
JOURNAL OF MOLECULAR BIOLOGY (2020)
Possible therapies of Parkinson's disease: A review
Ashok Chakraborty et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2020)
Structural Basis for Helicase-Polymerase Coupling in the SARS-CoV-2 Replication-Transcription Complex
James Chen et al.
CELL (2020)
Inhibition of α-Synuclein Aggregation and Mature Fibril Disassembling With a Minimalistic Compound, ZPDm
Samuel Pena-Diaz et al.
FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY (2020)
Rational design of small molecules able to inhibit α-synuclein amyloid aggregation for the treatment of Parkinson's disease
Serena Vittorio et al.
JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY (2020)
Synthesis of some new acylhydrazone compounds containing the 1,2,4-triazole structure and their neuritogenic activities in Neuro-2a cells
Xia Jiang et al.
RSC ADVANCES (2020)
Plant Extracts and Phytochemicals Targeting α-Synuclein Aggregation in Parkinson's Disease Models
Hayate Javed et al.
FRONTIERS IN PHARMACOLOGY (2019)
Targeting -Synuclein in Parkinson's Disease: Progress Towards the Development of Disease-Modifying Therapeutics
Daniel Savitt et al.
DRUGS (2019)
Toward the discovery and development of effective modulators of α-synuclein amyloid aggregation
Valentina Oliveri
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
α-Synuclein Dimers as Potent Inhibitors of Fibrillization
Yevhenii A. Kyriukha et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Current Drugs and Potential Future Neuroprotective Compounds for Parkinson's Disease
Ivan Carrera et al.
CURRENT NEUROPHARMACOLOGY (2019)
Natural compound safranal driven inhibition and dis-aggregation of α-synuclein fibrils
Shreyada S. Save et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2019)
ZPD-2, a Small Compound That Inhibits α-Synuclein Amyloid Aggregation and Its Seeded Polymerization
Samuel Pena-Diaz et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
Targeting Alpha-Synuclein as a Therapy for Parkinson's Disease
Carroll Rutherford Fields et al.
FRONTIERS IN MOLECULAR NEUROSCIENCE (2019)
Dopamine and Levodopa Prodrugs for the Treatment of Parkinson's Disease
Fatma Haddad et al.
MOLECULES (2018)
N-palmitoylethanolamide Prevents Parkinsonian Phenotypes in Aged Mice
Rosalia Crupi et al.
MOLECULAR NEUROBIOLOGY (2018)
2-Pentadecyl-2-Oxazoline Reduces Neuroinflammatory Environment in the MPTP Model of Parkinson Disease
Marika Cordaro et al.
MOLECULAR NEUROBIOLOGY (2018)
Subcellular localization of alpha-synuclein aggregates and their interaction with membranes
Fabiana Miraglia et al.
NEURAL REGENERATION RESEARCH (2018)
Small molecule inhibits α-synuclein aggregation, disrupts amyloid fibrils, and prevents degeneration of dopaminergic neurons
Jordi Pujols et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Emerging Treatment Approaches for Parkinson's Disease
Thomas B. Stoker et al.
FRONTIERS IN NEUROSCIENCE (2018)
High-Throughput Screening Methodology to Identify Alpha-Synuclein Aggregation Inhibitors
Jordi Pujols et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Prying into the Prion Hypothesis for Parkinson's Disease
Patrik Brundin et al.
JOURNAL OF NEUROSCIENCE (2017)
Liver X receptors activation, through TO901317 binding, reduces neuroinflammation in Parkinson's disease
Irene Paterniti et al.
PLOS ONE (2017)
Reactivity of Metal-Free and Metal-Associated Amyloid-β with Glycosylated Polyphenols and Their Esterified Derivatives
Kyle J. Korshavn et al.
SCIENTIFIC REPORTS (2015)
Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease
Jens Wagner et al.
ACTA NEUROPATHOLOGICA (2013)
Synthesis of some new 1,2,4-triazoles starting from isonicotinic acid hydrazide and evaluation of their antimicrobial activities
Hacer Bayrak et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2009)
Fiber diffraction of synthetic α-synuclein filaments shows amyloid-like cross-β conformation
LC Serpell et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)